SKI Market

Indian Indices

Nifty

26,068.15 -124.00
(-0.47%)

Sensex

85,231.92 -400.76
( -0.47%)

Bank Nifty

58,867.70 -480.00
( -0.81%)

Nifty IT

36,885.35 -157.95
( -0.43%)

Global Indices

Nasdaq

45,781.42 -378.36
(-0.82%)

Dow Jones

6,560.44 -102.72
(-1.54%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,572.31 64.90
(0.68%)

Forex

USD-INR

88.50 -0.07
(-0.08%)

EUR-INR

102.33 -0.31
(-0.31%)

GBP-INR

115.99 -0.49
(-0.42%)

JPY-INR

0.57 0.00
(-0.62%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1142.874838

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

30.49

68180.15

EPS(TTM)

Face Value()

Div & Yield %

187.01

0.79

Back

Sportking India standalone net profit declines 5.48% in the September 2025 quarter

Nov 13,2025

Net profit of Sportking India declined 5.48% to Rs 28.27 crore in the quarter ended September 2025 as against Rs 29.91 crore during the previous quarter ended September 2024. Sales declined 3.72% to Rs 627.39 crore in the quarter ended September 2025 as against Rs 651.65 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	627.39	651.65	-4
OPM %	10.42	9.60	-
PBDT	61.35	59.90	2
PBT	37.62	37.84	-1
NP	28.27	29.91	-5

26,068.15 -124.00 (-0.47%)

85,231.92 -400.76 ( -0.47%)

58,867.70 -480.00 ( -0.81%)

36,885.35 -157.95 ( -0.43%)

45,781.42 -378.36 (-0.82%)

6,560.44 -102.72 (-1.54%)

48,653.14 -1,170.80 (-2.35%)

9,572.31 64.90 (0.68%)

88.50 -0.07 (-0.08%)

102.33 -0.31 (-0.31%)

115.99 -0.49 (-0.42%)

0.57 0.00 (-0.62%)